References
- BartalCDanonASchlaefferFPharmacokinetic dosing of aminoglycosides: a controlled trialAm J Med2003114319419812637133
- SchiffelersRStormGBakker-WoudenbergILiposome-encapsulated aminoglycosides in pre-clinical and clinical studiesJ Antimicrob Chemother200148333334411532996
- WilsonJFDavisACTobinCMEvaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessmentJ Antimicrob Chemother2003521788212805260
- HammondLJGaldwellSCampbellPWCystic fibrosis, intravenous antibiotics, and home therapyJ Pediatr Health Care19915124301990112
- ShahSMisraALiposomal amikacin dry powder inhaler: effect of fines on in vitro performanceAAPS Pharm Sci Tech200454e65
- CullenABCoxCAHippSJWolfsonMRShafferTHIntra-tracheal delivery strategy of gentamicin with partial liquid ventilationResp Med19999311770778
- AtyabiFTalaieFDinarvandRThiolated chitosan nanoparticles as an oral delivery system for amikacin: in vitro and ex vivo evaluationsJ Nanosci Nanotechnol2009984593460319928123
- VarshosazJGhaffariSKhoshayandMRAtyabiFAzarmiSKobarfardFDevelopment and optimization of amikacin solid lipid nanoparticles by central composite designJ Liposome Res20102029710419621981
- BaraniHMontazerMA review on applications of liposomes in textile processingJ Liposome Res200818324926218770074
- MullerHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
- ZhangNPingQHuangGXuWChengYHanXLecitin-modified solid lipid nanoparticles as carriers for oral administration of insulinInt J Pharm20063271215315916962267
- SweetmanSCThe Complete Drug Reference35th edLondon, UKChicago Pharmaceutical Press (PhP)2007
- BeaulacCSachetelliSLagaceJIn vitro bactericidal efficacy of sub-MIC concentration of liposome encapsulated antibiotic against gram- negative and gram- positive bacteriaJ Antimicrob Chemother199841135419511035
- GazoriTKhoshayandMRAziziEYazdizadePNomaniAHaririanIEvalution of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization, and in vitro characterizationCarbohyd Polym2009773599606
- VarshosazJGhaffariSKhoshayandMRAtyabiFOptimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental designPharm Dev Tech2010 In press
- VivekKReddyHMurthyRInvestigation of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticlesAAPS Pharm Sci Tech2007841624
- LarsonTAPetersonLRGerdingDNMicrodilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organismsJ Clin Microbiol19852258198213932459
- SiddiqiSHeifetsLBCynamonMRapid broth macrodilution method for determination of MICs for Mycobacterium avium isolatesJ Clin Microbiol1993319233223388408551
- BermudezLEWuMYoungLSIntracellular killing of Mycobacterium avium complex by rifapentine and liposome-incapsulated amikacinJ Infect Dis198715635105133611835
- PoynerEAAlparHOAlmeidaAJGambleMDBrownMRWA comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal deliveryJ Control Rel19953514148